November 24, 2025

Oral PCSK9 Inhibitor Tied to LDL-C Drop

The oral PCSK9 inhibitor enlicitide decanoate achieved 58% LDL-C reduction in patients with heterozygous familial hypercholesterolemia, offering a potential alternative to injectable therapies.

Conexiant

November 21, 2025

EULAR: Issues With the RA Definition?

Researchers examine the strengths and shortcomings of the current European Alliance of Associations for Rheumatology definition for difficult-to-treat rheumatoid arthritis.

Conexiant

November 21, 2025

Which Antidepressants Shift Physiology?

Researchers found differences in how antidepressants affect weight, blood pressure, heart rate, and other physiological parameters.

Conexiant

November 20, 2025

Biomarkers Flag Recurrent Miscarriage

A machine-learning approach evaluated whether metabolite patterns signaled miscarriage risk.

Conexiant

November 20, 2025

Root Canals: The Systemic Effect

Two-year study finds successful endodontic therapy associated with improved glucose and lipid metabolism in patients with apical periodontitis.

Conexiant

November 18, 2025

‘Designed to Scare People’? New Contraception Data

Hormonal contraception shows overall safety with a modest, short-term rise in breast cancer risk.

KFF Health News

November 18, 2025

Plozasiran Wins FDA Nod for FCS

Arrowhead’s small interfering RNA therapy reduced triglycerides and lowered pancreatitis risk in the phase 3 PALISADE trial, providing a quarterly self-administered option for patients with familial chylomicronemia syndrome.

Conexiant

November 17, 2025

Active PsA Linked to Maternal Hypertension in Pregnancy

Researchers explore links between psoriatic arthritis and maternal health.

Conexiant

November 14, 2025

The Risk Factor Going Unscreened

Adverse childhood experiences drive elevated all-cause mortality across medical conditions, with emergency department patients also showing nearly double the death rates.

Conexiant